CPMG Inc
- SEC CIK
- 0001372218
- Latest filing
- May 15, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 17, 2021. Long positions only.
- Positions
- 4
- No 13F data for Q4 2020
- Portfolio value
- $522.9M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RETAReata Pharmaceuticals Inc | CL A | 2,896,901 | $288.8M | 55.2% | – | – | History |
| TILInstil Bio, Inc. | COM | 8,478,790 | $212.6M | 40.7% | – | – | History |
| APENApollo Endosurgery, Inc. | COM | 3,169,845 | $17.5M | 3.3% | – | – | History |
| Invesco QQQ Trust Series I46090E103 | ETF | 12,299 | $3.92M | 0.8% | – | – | – |